Barnett E D, Klein J O
Department of Pediatrics, Maxwell Finland Laboratory for Infectious Diseases, Boston, Massachusetts, USA.
Pediatr Clin North Am. 1995 Jun;42(3):509-17. doi: 10.1016/s0031-3955(16)38976-3.
The emergence of pneumococci resistant to penicillin has prompted an examination of the role of resistant organisms in the response to treatment for AOM. At this time, antibiotic-resistant organisms play a small role in the number of episodes of AOM that do not respond to initial therapy. Amoxicillin remains the drug of choice for treatment of AOM. For children who do not respond, assessment of clinical status is important. Children who are well-appearing may respond to a beta-lactamase stable oral agent. Children who are ill may require tympanostomy and presumptive therapy for infection due to resistant organisms.
对青霉素耐药的肺炎球菌的出现促使人们审视耐药菌在急性中耳炎(AOM)治疗反应中的作用。目前,抗生素耐药菌在初始治疗无反应的AOM发作病例数中所起的作用较小。阿莫西林仍然是治疗AOM的首选药物。对于无反应的儿童,评估临床状况很重要。看起来状况良好的儿童可能对β-内酰胺酶稳定的口服药物有反应。病情较重的儿童可能需要鼓膜造孔术,并针对耐药菌感染进行经验性治疗。